Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating autologous hematopoietic stem cell transplantation for Crohn's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Autologous hematopoietic stem cell transplantation (Autologous hematopoietic stem cell transplantation)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Crohn's Disease | EARLY_Phase 1 | Status: WITHDRAWN